FDA
-
-
-
-
-
-
-
Bernstein on US Life Science Tools & Diagnostics: 'Why We're More Bullish...'
-
-
-
-
-
-
-
Activist investor Keith Meister to join Illumina's board
-
-
-
-
-
-
-
FDA approves Illumina cancer biomarker test with two companion diagnostics to rapidly match patients to targeted therapies
-
-
-
-
-
-
-
GRAIL Presents New Data on GalleriĀ® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
-
-
-
-
-
-
-
GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of Galleriā Multi-Cancer Early Detection (MCED) Test Among The Medicare Population
-
-
-
-
-
-
-
Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
-
-
-
-
-
-
-
Illumina (ILMN) Sends Letter to Shareholders Highlighting Board Strength, Weakness of Icahn's "Plan"
-
323,128 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

